Listen on the go
CORRECT!
Next question
touchCARDIO touchCARDIO
    • FILTER YOUR SEARCH
    Content Type:
    Speciality:
    More Specialities
    Conference:
    More Conferences

    • Cardiovascular Disease

    EU Partner

    US Partner

    World Partner

    An Introduction to Cardiovascular Disease

    Cardiovascular diseases (CVDs) are the number one cause of death globally, taking an estimated 17.9 million lives each year. CVDs describe a number of conditions affecting the heart and circulation, including coronary heart disease, angina, congenital heart disease, hypertension and stroke. The huge and ever-increasing burden of CVDs on individuals and healthcare systems shows the urgent ongoing need for treatments and preventive measures.

    Browse the content below where leading experts discuss the latest data in video interviews and short articles from our conference hub, and browse the selection of peer-reviewed articles from our journal portfolio. If you are looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.

    Our supporting partners do not constitute an endorsement of the content on this page.

    Cardiovascular Disease Content

    Cardiovascular Disease
    Human heart with red cardio pulse line. Creative stylized red heart cardiogram with human heart on black background. Health, cardiology, cardiovascular diseases concept
    Understanding Diabetic Cardiomyopathy: Insulin Resistance and Beyond
    Aditya John Binu, Nitin Kapoor

    Heart International. 2024;18(2):7-13

    Cardiovascular disease (CVD) is a significant cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). An estimated 60–80% of patients with T2DM die of cardiovascular events.1,2 A bidirectional relationship has been noted between heart failure (HF) and T2DM.3 HF was noted to be twice as high in male patients and five times as […]

    touchDATA POINT
    Long-term hepatic safety of cholesterol-lowering MTP inhibitor therapy in homozygous familial hypercholesterolemia
    For HCPs in: Europe, Saudi Arabia and Israel
    View Time: 5 mins Sponsored content

    In this engaging short animation, learn how cholesterol-lowering MTP inhibitors act to reduce cholesterol in people with homozygous familial hypercholesterolemia, and explore clinical data supporting their long-term hepatic safety.

     

    Code: LOM/EU/015
    Date of Preparation: November 2024
    Arrhythmia, Atherosclerosis, Atrial Fibrillation, Cardiovascular Disease, Congenital Conditions, COVID-19, Electrophysiology, Heart Failure, Hypertension, Imaging, Interventional Cardiology, Thrombosis, Stroke
    Heart International achieves new Impact Factor milestone of 1.9 in 2024 Journal Citation Reports

    touchCARDIO is delighted to announce that Heart International has received an impressive new Impact Factor of 1.9 in the 2024 Journal Citation Reports (JCR). This achievement marks a notable increase from last year’s Impact Factor of 0.2 and highlights the journal’s growing influence in the cardiology field.

    Cardiovascular Disease
    Developed by Touch
    Artificial intelligence enabled obstetric cardiovascular screening in SPEC-AI Nigeria
    Demilade Adedinsewo Watch Time: 7.33 minutes

    touchCARDIO coverage of data presented at ESC 2024 touchCARDIO spoke with Dr Demilade Adedinsewo, non-invasive cardiologist at Mayo Clinic, Jacksonville, FL, USA to discuss artificial intelligence-enabled obstetric cardiovascular screening in the SPEC-AI Nigeria randomized clinical trial (ClinicalTrials.gov identifier: NCT05438576). The SPEC-AI Nigeria study aimed to enhance the early detection of pregnancy-related heart disease, particularly in Nigeria, […]

    Cardiovascular Disease
    Developed by Touch
    Alipoprotein A-I infusions and cardiovascular outcomes
    Charles Michael Gibson Watch Time: 5.08 minutes

    touchCARDIO spoke with Dr Mike Gibson, Harvard Medical School, Boston, MA, USA to discuss the results of his trial investigating the relationship between apolipoprotein A-I infusions and cardiovascular outcomes, presented at ESC 2024. He explains that while high-density lipoprotein (HDL) is generally associated with good outcomes, not all HDL is equally effective at removing cholesterol from plaque, a process known as cholesterol efflux, which is crucial for better outcomes after a heart attack.

    Cardiovascular Disease
    Erratum to Correct Errors in Text
    Adam Ioannou

    Heart International. 2024;18(2):3

    This corrects the article: “Ioannou A. Evolution of Disease-modifying Therapy for Transthyretin Cardiac Amyloidosis. Heart International. 2024;18(1):30-37”. Two typography errors were included incorrectly due to an editorial error. In Table 1, “eplontersen” was incorrectly written as “eplomtersen”. This has been corrected in the text. In the section “Eplontersen”, the administration schedule should be written as […]

    Cardiovascular Disease
    Watch Time: 34 mins
    touchEXPERT OPINIONS
    The path from detection to personalized long-term care for Fabry disease
    CE/CME ACCREDITED Prof. Aleš Linhart, Dr Eric Wallace, Prof. William Wilcox Translations available:

    Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.

    Learning objectives
    Learning Objectives
    • Recognize the importance of early diagnosis and detection of organ involvement in Fabry disease in establishing an effective management plan for individual patients
    • Assess strategies for the long-term monitoring and follow-up of patients with Fabry disease for improved treatment adherence and quality of life
    • Discuss emerging therapeutic options and how they may change the future management of patients with Fabry disease
    Arrhythmia, Cardiovascular Disease, Heart Failure, Hypertension
    ESC 2024 preview: Personalising cardiovascular care

    The ESC Congress is a key event in our conference calendar, and this year, London will welcome thousands of cardiologists and allied healthcare professionals. Together, they will work to transform patient care and advance the field through cutting-edge research, pioneering technologies, and collaborative initiatives.

    Cardiovascular Disease
    Are heart health improvements reaching everyone?

    A new study in the BMJ has analyzed cardiovascular disease (CVD) trends among 22 million UK residents over the last 20 years, revealing both progress and persistent challenges. The research shows a significant decrease in heart attacks and strokes, thanks to better management of risk factors like high blood pressure and smoking cessation. However, the […]

    In Partnership with...
    Useful Links:
    About us Society Partners Press Releases Contact Us Permissions Terms & Conditions Privacy Policy Cookie Preferences
    Connect With Us:

    Other websites from Touch Medical Media:

    touchONCOLOGY
    touchOPHTHALMOLOGY
    touchENDOCRINOLOGY
    touchNEUROLOGY
    touchCARDIO
    touchRESPIRATORY
    touchIMMUNOLOGY
    touchINFECTIOUS DISEASES
    touchHAEMATOLOGY
    touchDERMATOLOGY

    Copyright® 2024 Touch Medical Media. Touch Medical Media Group Holdings Limited, a private limited company registered in England and Wales at 3 Stockport Exchange | Stockport | Cheshire | SK1 3GG | UK with registered number 08197142.

    touchCARDIO is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.

    Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
    Close Popup